Patents by Inventor Anke Baum

Anke Baum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050244413
    Abstract: The invention relates to the combined use of conjugates of CD44 specific antibodies with cytotoxic compounds and chemotherapeutic agents in cancer therapy, pharmaceutical compositions comprising such compounds and/or chemotherapeutic agents, and methods of cancer treatment. Preferred conjugates contain maytansinoids as cytotoxic compounds, and preferred chemotherapeutic agents are taxanes, epothilones, and vinca alcaloids.
    Type: Application
    Filed: June 30, 2005
    Publication date: November 3, 2005
    Inventors: Guenther Adolf, Anke Baum, Karl-Heinz Heider
  • Patent number: 6861422
    Abstract: The present invention relates to new dihydropteridinones of general formula (I): wherein the groups L and R1-R5 have the meanings given in the claims and specification, the isomers thereof, processes for preparing these dihydropteridinones and the use thereof as pharmaceutical compositions.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: March 1, 2005
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Matthias Hoffmann, Matthias Grauert, Trixi Brandl, Steffen Breitfelder, Christian Eickmeier, Martin Steegmaier, Gisela Schnapp, Anke Baum, Jens Juergen Quant, Flavio Solca, Florian Colbatzky
  • Publication number: 20050043233
    Abstract: The present invention relates to a pharmaceutical combination for the treatment of diseases which involves cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The invention also relates to a method for the treatment of said diseases, comprising co-administration of effective amounts of specific active compounds and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of these specific compounds and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.
    Type: Application
    Filed: April 22, 2004
    Publication date: February 24, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Martin Stefanic, Frank Hilberg, Gerd Munzert, Flavio Solca, Anke Baum, Jacobus van Meel
  • Publication number: 20050014761
    Abstract: Disclosed are new dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and specification, the isomers thereof, intermediates and processes for preparing these dihydropteridinones and the use thereof as pharmaceutical compositions.
    Type: Application
    Filed: July 30, 2004
    Publication date: January 20, 2005
    Inventors: Matthias Hoffmann, Matthias Grauert, Trixi Brandl, Steffen Breitfelder, Christian Eickmeier, Martin Steegmaier, Gisela Schnapp, Anke Baum, Jens Quant, Flavio Solca, Florian Colbatzky
  • Publication number: 20050014760
    Abstract: Disclosed are new dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and specification, the isomers thereof, intermediates and processes for preparing these dihydropteridinones and the use thereof as pharmaceutical compositions.
    Type: Application
    Filed: July 30, 2004
    Publication date: January 20, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Matthias Hoffmann, Matthias Grauert, Trixi Brandl, Steffen Breitfelder, Christian Eickmeier, Martin Steegmaier, Gisela Schnapp, Anke Baum, Jens Quant, Flavio Solca, Florian Colbatzky
  • Publication number: 20040176380
    Abstract: The present invention relates to new dihydropteridinones of general formula (I) 1
    Type: Application
    Filed: February 26, 2003
    Publication date: September 9, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH Co. KG
    Inventors: Matthias Hoffmann, Matthias Grauert, Trixi Brandl, Steffen Breitfelder, Christian Eickmeier, Martin Steegmaier, Gisela Schnapp, Anke Baum, Jens Juergen Quant, Flavio Solca, Florian Colbatzky
  • Publication number: 20040126379
    Abstract: The invention relates to the combined use of conjugates of CD44 specific antibodies with cytotoxic compounds and chemotherapeutic agents in cancer therapy, pharmaceutical compositions comprising such compounds and/or chemotherapeutic agents, and methods of cancer treatment. Preferred conjugates contain maytansinoids as cytotoxic compounds, and preferred chemotherapeutic agents are taxanes, epothilones, and vinca alcaloids.
    Type: Application
    Filed: August 21, 2003
    Publication date: July 1, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Guenther Adolf, Anke Baum, Karl-Heinz Heider
  • Publication number: 20020173509
    Abstract: A compound of general formula I 1
    Type: Application
    Filed: December 17, 2001
    Publication date: November 21, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Anke Baum, Flavio Solca
  • Publication number: 20020169180
    Abstract: The present invention relates to bicyclic heterocycles of general formula 1
    Type: Application
    Filed: December 10, 2001
    Publication date: November 14, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Thomas Metz, Flavio Solca, Birgit Jung, Anke Baum